Close Menu

This article has been updated to include additional information about the size of Ginkgo Bioworks' award from the NIH.

NEW YORK – The National Institutes of Health said on Friday that it is awarding a total of $248.7 million in contracts to seven biomedical diagnostic companies under its Rapid Acceleration of Diagnostics (RADx) initiative, to support a range of new lab-based and point-of-care tests for the detection of SARS-CoV-2, the virus causing the COVID-19 pandemic.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.